DEVELOPMENT AND EVALUATION OF CHITOSAN-BASED MICONAZOLE NITRATE NANOPARTICLES PREPARED BY IONIC GELATION METHOD

Nanoparticles of miconazole nitrate were successfully prepared using the ionic gelation method. Pre-formulation studies such as solubility, melting point, FTIR, DSC, and UV spectroscopy confirmed that there was no interference between the drug and excipients. Among the different formulations tested, F1 was chosen as the optimized formulation because it showed high drug content, high entrapment efficiency, good stability, and the highest drug release over 12 hours. The in vitro release study demonstrated that cumulative drug release ranged from 80.11% for F1 to 71.27% for F4, with drug release decreasing as polymer concentration increased due to the denser matrix hindering diffusion. Kinetic analysis revealed that drug release followed the Higuchi model, indicating that diffusion through the polymer matrix. Additionally, polymer relaxation and erosion also contributed to the release process, as indicated by Peppas’ 'n' values above 0.5. Overall, the study shows that the drug release from the nanoparticles is sustained, influenced by polymer concentration and matrix characteristics.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-10-15
DOI
https://doi.org/10.5281/zenodo.17366659
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DEVELOPMENT AND EVALUATION OF CHITOSAN-BASED MICONAZOLE NITRATE NANOPARTICLES PREPARED BY IONIC GELATION METHOD

Zenodo (CERN European Organization for Nuclear Research)
Drug Solubulity and Delivery Systems
article

DEVELOPMENT AND EVALUATION OF CHITOSAN-BASED MICONAZOLE NITRATE NANOPARTICLES PREPARED BY IONIC GELATION METHOD

article en

Abstract

Nanoparticles of miconazole nitrate were successfully prepared using the ionic gelation method. Pre-formulation studies such as solubility, melting point, FTIR, DSC, and UV spectroscopy confirmed that there was no interference between the drug and excipients. Among the different formulations tested, F1 was chosen as the optimized formulation because it showed high drug content, high entrapment efficiency, good stability, and the highest drug release over 12 hours. The in vitro release study demonstrated that cumulative drug release ranged from 80.11% for F1 to 71.27% for F4, with drug release decreasing as polymer concentration increased due to the denser matrix hindering diffusion. Kinetic analysis revealed that drug release followed the Higuchi model, indicating that diffusion through the polymer matrix. Additionally, polymer relaxation and erosion also contributed to the release process, as indicated by Peppas’ 'n' values above 0.5. Overall, the study shows that the drug release from the nanoparticles is sustained, influenced by polymer concentration and matrix characteristics.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 51%
Drug Solubulity and Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.